The effectiveness of liver transplantation in reducing lipid levels in Saudi children with homozygous familial hypercholesterolemia

Abdullah Al-Ashwal,Salman Al-Mansour,Mohammed Al-Shagrani,Talal Al-Gofi,Dieter Broering,Raghad Alhuthil
DOI: https://doi.org/10.3389/fcvm.2024.1454638
IF: 3.6
2024-11-21
Frontiers in Cardiovascular Medicine
Abstract:Introduction: The lipid profiles of patients aged <15 years who have been diagnosed with homozygous familial hypercholesterolemia (HoFH) at King Faisal Specialist Hospital & Research Center (Riyadh) were examined. Methods: The total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels of 17 patients were measured on initial presentation and compared with the levels measured after pharmacological treatment and then again after liver transplantation. Results: At the end of the pharmacological treatment, the total cholesterol levels decreased by an average of 3.79 mmol/L (reduced by 15.40%) ( P < 0.001), and LDL-C levels decreased on average by 2.73 mmol/L (reduced by 13.46%) ( P = 0.014). However, in two patients, LDL-C levels increased by 5.42% and 9.03% after pharmacological treatment. Conversely, the lipid values measured after liver transplantation decreased significantly nearly to within normal and borderline limits. The post-transplant total cholesterol and LDL-C levels declined by a mean of 19.96 mmol/L (reduced by 81.04%) and 17.47 mmol/L (reduced by 84.27%), respectively ( P < 0.001 for both). Discussion: These findings suggest that liver transplantation provides a more effective means to reduce elevated total cholesterol and LDL-C levels in patients with HoFH. Although liver transplantation is considered a better treatment for FHoH, risks, complications, and donor organ shortage may present problems.
cardiac & cardiovascular systems
What problem does this paper attempt to address?